Vir Biotechnology, Inc.·4

Jun 2, 12:20 PM ET

Rice Steven J. 4

4 · Vir Biotechnology, Inc. · Filed Jun 2, 2023

Insider Transaction Report

Form 4
Period: 2023-06-01
Rice Steven J.
Chief Administrative Officer
Transactions
  • Sale

    Common Stock

    2023-06-01$25.67/sh2,500$64,175106,840 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2023.
  • [F2]Includes 926 shares of common stock acquired by the reporting person on May 31, 2023 pursuant to an employee stock purchase program.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24

    POA DOCUMENT